Zydus Lifesciences Limited acquires Agenus
Zydus Lifesciences Limited agreed to acquire Agenus. Reported deal value: Undisclosed. Status: Completed. Sector: Biopharmaceuticals. Target headquarters context: Lexington, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-15. Figures and status may change as filings and press coverage update.
Today at 9:58 AM Zydus Completes Agenus Biologics Facilities Acquisition And Launches U.S. CDMO Unit Zydus Lifesciences Limited announced it has completed a set of agreements with Agenus Inc. that transfers ownership of Agenus ’ biologics manufacturing facilities and operations to Zydus , establishing a new U.S. -based platform that will operate under a newly formed subsidiary, Zylidac Bio LLC
Deal timeline
This transaction is classified in Biopharmaceuticals. Figures and status may change as sources update.